| Literature DB >> 22846144 |
Rubén E Mújica Mota1, Rosanna Tarricone, Oriana Ciani, John F P Bridges, Mike Drummond.
Abstract
BACKGROUND: Documented age, gender, race and socio-economic disparities in total joint arthroplasty (TJA), suggest that those who need the surgery may not receive it, and present a challenge to explain the causes of unmet need. It is not clear whether doctors limit treatment opportunities to patients, nor is it known the effect that patient beliefs and expectations about the operation, including their paid work status and retirement plans, have on the decision to undergo TJA. Identifying socio-economic and other determinants of demand would inform the design of effective and efficient health policy. This review was conducted to identify the factors that lead patients in need to undergo TJA.Entities:
Mesh:
Year: 2012 PMID: 22846144 PMCID: PMC3483199 DOI: 10.1186/1472-6963-12-225
Source DB: PubMed Journal: BMC Health Serv Res ISSN: 1472-6963 Impact factor: 2.655
Figure 1Process of identification of demand studies.
Quality checklist
| | ■ | | ■ | ■ | | | ■ | | ■ | ■ | ■ | | ■ | ■ | ■ | ■ | ■ | ■ | ■ | | | ■ | ■ | | ■ | |
| | ■ | ■ | ■ | | ■ | | ■ | ■ | ■ | ■ | ■ | | | ■ | | ■ | ■ | ■ | ■ | ■ | ■ | ■ | ■ | ■ | ■ | |
| ■ | ■ | ■ | ■ | ■ | ■ | ■ | ■ | ■ | ■ | ■ | ■ | ■ | ■ | ■ | ■ | ■ | ■ | ■ | ■ | | ■ | ■ | ■ | ■ | ■ | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
| - | | | | ■ | | ■ | ■ | ■ | ■ | ■ | ■ | ■ | | | ■ | ■ | ■ | | ■ | ■ | | | ■ | ■ | ■ | ■ |
| - | ■ | | ■ | ■ | | ■ | ■ | ■ | ■ | ■ | ■ | ■ | | | ■ | ■ | | | | ■ | | | ■ | ■ | | ■ |
| - | | | | | ■ | | | | ■ | ■ | | | ■ | | ■ | | | | | | | ■ | ■ | ■ | | |
| - | | | | ■ | | | | | ■ | ■ | | ■ | | | | | ■ | | | | | | ■ | | | ■ |
| - | | ■ | | ■ | | | | | ■ | | | | | | | | | | | | | | ■ | ■ | | |
| - | | | | ■ | | ■ | | ■ | ■ | ■ | ■ | ■ | | ■ | | ■ | ■ | | ■ | ■ | | | ■ | | | |
| - | | | | | | | | | | | | | | | | | | | | | | | | | | ■ |
| - | | | | ■ | | | ■ | | | ■ | | ■ | | | | | | | | | | | ■ | | | |
| - | | | | | | | | | ■ | ■ | ■ | ■ | | | | | | | | | | ■ | | | | |
| - | | | | | ■ | | ■ | ■ | ■ | ■ | | | | | | | | | | | | | | | | |
| - | | | | | ■ | ■ | | | ■ | ■ | ■ | ■ | | | | | | | | | | ■ | ■ | ■ | | |
| - | | | | ■ | | | | | | | | ■ | | | ■ | | | | | | | | | | | |
| - | | | | | | | | | | | | | | | ■ | | | | | | | | | | | |
| - | ■ | | | ■ | | ■ | ■ | ■ | ■ | ■ | ■ | ■ | ■ | | ■ | | ■ | ■ | ■ | ■ | | | ■ | ■ | | ■ |
| ■ | | ■ | ■ | ■ | ■ | ■ | | | ■ | ■ | ■ | | | ■ | ■ | ■ | ■ | | ■ | | ■ | ■ | ■ | ■ | | |
| | ■ | | ■ | | ■ | ■ | | ■ | ■ | ■ | ■ | | | ■ | ■ | ■ | | ■ | ■ | ■ | | ■ | ■ | ■ | ■ | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
| - | | ■ | | ■ | | | ■ | | ■ | ■ | ■ | ■ | | ■ | ■ | ■ | ■ | ■ | | ■ | ■ | | | ■ | ■ | ■ |
| - | | ■ | | ■ | | | ■ | | | | ■ | ■ | | ■ | ■ | ■ | ■ | ■ | | ■ | ■ | | ■ | ■ | ■ | |
| - | | ■ | | ■ | | | ■ | | | | ■ | ■ | | ■ | ■ | ■ | ■ | ■ | ■ | ■ | ■ | | ■ | ■ | ■ | |
| ■ | ■ | ■ | ■ | ■ | ■ | ■ | ■ | ■ | ■ | ■ |
1. Birk and Henriksen, 2006 [54] 2. Birrel et al., 2003 [22] 3. Borkhoff et al., 2008 [55] 4. Boutron et al., 2008 [60] 5. Card et al., 2008 [47] 7. Cross et al., 2000 [79] 13. Ibrahim et al., 2002 [39] 19. Momohara et al., 2007 [23] 26. Yong., et al. 2004 [48].
6. Conner-Spady et al., 2008 [53] 7. Cross et al., 2000 [79] 8. Dunlop et al., 2003 [29] 9. George et al., 2008 [20] 10. Hanchate, 2008 [21] 2. Birrel et al., 2003 [22] 8. Dunlop et al., 2003 [29] 14. Johnson et al., 2008 [61] 20. Quintana et al., 2006 [59] 27. Zeni et al., 2010 [18].
11. Hawker et al., 2006 [26] 12. Hawker et al., 2000 [30] 13. Ibrahim et al., 2002 [40] 14. Johnson et al., 2008 [61] 15. Judge et al., 2010 [28] 3. Borkhoff et al., 2008 [55] 9. George et al., 2008 [20] 15. Judge et al., 2010 [28] 21. Riddle et al., 2009 [78].
16. Juni et al., 2010 [37] 17. Lievense et al., 2007 [19] 18. Linsell et al., 2005 [52] 19. Momohara et al., 2007 [23] 20. Quintana et al., 2006 [59] 4. Boutron et al., 2008 [60] 10. Hanchate, 2008 [21] 16. Juni et al., 2010 [37] 22. Schonberg et al., 2009 [46].
21. Riddle et al., 2009 [78] 22. Schonberg et al., 2009 [46] 23. Steel et al., 2008 [38] 24. Suarez-Almazor et al., 2005 [44] 25. Yong et al., 2004 [48] 5. Card et al., 2007 [47] 11. Hawker et al., 2006 [26] 17. Lievense et al., 2007 [19] 23. Steel et al., 2008 [38].
26. Zeni et al., 2008 [18] 6. Conner-Spady et al., 2008 [53] 12. Hawker et al., 2000 [30] 18. Linsell et al., 2005 [52] 24. Suarez- Almazor et al., 2008.
Summary of quality of identified quantitative studies
| Borkhoff [ | Primary care and surgeons | Knee | Referral | 3 | No(standardised cases) |
| Boutron [ | Primary care doctors | Knee and hip | Referral | 4 | Yes |
| Quintana [ | Specialists | Knee and hip | Recommendation | 3 | Yes |
| Birk [ | Waiting list patients | Knee and hip | Decision to change surgeon | 2 | No |
| Birrell [ | Primary care patients | Hip | Waiting list placement | 2 | Yes |
| Card [ | Older adults | Hip and knee | Arthroplasty | 2 | Yes |
| Conner-Spady [ | Waiting list patients | Knee and hip | Hypothetical change of surgeon | 3 | No |
| Cross [ | Operated patients | Knee and hip | Willingness to pay | 3 | No |
| Dunlop [ | Older adults | Knee and hip | Arthroplasty | 2 | Yes |
| George [ | OA Medicare patients | Hip | Arthroplasty | 3 | No |
| Hanchate [ | Older adults | Knee | Arthroplasty | 3 | Yes |
| Hawker [ | OA patients | Knee and hip | Arthroplasty | 4 | Yes |
| Hawker [ | OA patients | Knee and hip | Willingness to operate | 3 | Yes |
| Ibrahim [ | Primary care males VA patients | Knee and hip | Willingness to operate | 1 | No |
| Johnson [ | Primary care patients | Hip | Waiting list placement | 1 | Yes |
| Judge [ | Older adults | Knee and hip | Arthroplasty | 2 | Yes |
| Juni [ | Primary care patients | Knee and hip | Waiting list placement/Willingness to operate | 1 | Yes |
| Lievense [ | Primary care patients | Hip | Arthroplasty | 2 | Yes |
| Linsell [ | Retirement age adults | Hip and knee | Willingness to operate | 2 | Yes |
| Momohara [ | RA patients | Knee | Arthroplasty | 2 | Yes |
| Riddle [ | OA patients | Knee | Arthroplasty | 2 | No |
| Schonberg [ | Retirement age OA patients | Knee and hip | Referral | 2 | No |
| Steel [ | OA/RA patients | Knee and hip | Arthroplasty | 3 | Yes |
| Suarez-Almazor [ | OA patients | Knee | Willingness to operate | 3 | Yes |
| Yong [ | Non-obese retirement age adults | Knee | Arthroplasty | 2 | No |
| Zeni [ | OA patients | Knee | Arthroplasty | 2 | Yes |
*Sum of individual internal validity criterion rating (1 = study met criterion; 0 otherwise; maximum score: 4). Criteria: Prospective/longitudinal study and analysis; adjustment for confounding; reporting of attrition; doctor-assessed need.
Figure 2 Ratios: a) age ≥ 60 to age 50–59 surgery rates (left) and b) propensity for surgery at age > 62 relative to age ≤62 rate (right). * Rates in public hospitals in England, adjusting for gender, ward ethnic mix and deprivation, distance to and characteristics of hospitals [28]. ** Rate of receipt of primary surgery after five years, based on population samples from two areas of Ontario, Canada. Relative to age ≤ 62. Adjusting for WOMAC, SF-36 General Health, Willingness to undergo surgery [26].
Figure 3 Ratio of male to female surgery rate. *U.S. population-based study age ≥ 47. Patients with an arthritis-related visit to the doctor in the past two years at baseline. Adjusted for age, gender, race, comorbidities, functional limitations, income, wealth, insurance type, employment, and BMI ≥ 25 [21]. ~ Rate over 18 months, from south of England study of patients aged ≥65. Unadjusted for confounders [48]. #Surgical rates in public hospitals, population of England. One year incidence, adjusted for socio-economic and ethnicity mix of ward of residence [28]. ^Respondents reporting an arthritis-related visit at baseline. Adjusting for demographics, health need and economic access (including health insurance, wealth and education) [38].
Figure 4 Ratio of surgical rate and willingness to undergo surgery by race minority group to white. Dunlop: Adjusting for demographics, health need and economic access (including health insurance, wealth and education). Black/Hispanic refers to all respondents; Black/Hispanic^ refers to respondents reporting an arthritis-related visit at baseline [29]. Steel: Adjusting for covariates age, gender, wealth, employment, BMI ≥ 30, seen doctor ≥2 times in last 2 years, education, comorbidity, grandchild care, difficulty walking 1 block or more, married/cohabiting. Other category is defined as non-black and non-white [38]. Ibrahim: AA African-American sample adjusting for age, level of education, annual income, radiologic severity of disease, WOMAC, geriatric depression score; AA* Adjusting for familiarity with surgery in addition to covariates for AA[40]; AA** Adjusting for familiarity and expectations in addition to covariates for AA [40]. Suarez-Almazor: Adjusted for age, gender, years of education, trust in physician, perception of efficacy, perception of risk, WOMAC, relative/friend with TKA. AA refers to African American sample [44].
Figure 5 Ratio of surgical rate with post-secondary education to rate with lower education level. Hanchate: Relative to less than high school education. U.S. population-based study age ≥ 47. Adjusted for age, gender, race, comorbidities, functional limitations, income, wealth, insurance type, employment, BMI ≥ 25. *Refers to respondents with an arthritis-related visit to the doctor in the past two years at baseline; other result refers to all respondents [21]. Hawker: Relative to less than high school education. Sample from two areas in Ontario, Canada. Adjusting for WOMAC, SF-36 General Health, age [26]. Steel: Relative to less than college education. U.S. population-based study age ≥ 60. Adjusting for covariates age, gender, wealth, employment, BMI ≥ 30, seen doctor ≥2 times in past 2 years, comorbidity [38].
Figure 6 Ratio of surgical rate overweight (BMI ≥ 25) or obese (BMI ≥ 30) to rate with a lower BMI. ^U.S. population-based study age ≥ 47. Patients with an arthritis-related visit to the doctor in the past two years at baseline. Adjusted for age, gender, race, comorbidities, functional limitations, income, wealth, insurance type, employment, and education [21]. *Arthritis subsample. Other details as in Footnote ^. **Three-year rate. Adjusted for age, morning stiffness, Kellgren-Lawrence ≥ 2, worst pain location, function with decreased active hip motion [19]. ***Six-year rate. Other details as in Footnote **. ~U.S. population-based study age ≥ 60. Adjusting for covariates age, sex, wealth, employment, seen doctor ≥2 times in past 2 years, education, and comorbidity [38].
Specialist referral and waiting list prioritisation instruments, levels and scores for THA and TKA
| Moderate | 0 | None | 0 | | | | ||
| | Severe | 18 | | Mild | 6 | | | |
| | | | | Moderate | 15 | | | |
| | | | | Severe | 30 | | | |
| | | | None | 0 | None/mild | 0 | ||
| | | | | Mild | 2 | | Moderate | 5 |
| | | | | Moderate | 5 | | Severe | 9 |
| | | | | Severe | 10 | | | |
| | | | No | 0 | | | | |
| | | | | Yes, affected joints with moderate severity | 4 | | | |
| | | | | Yes, severe involvement | 10 | | | |
| Mild | 0 | None | 0 | None/mild | 0 | |||
| | Moderate | 17 | | Mild | 4 | | Moderate | 13 |
| | Severe | 33 | | Mild to moderate | 6 | | Severe | 20 |
| | | | | Moderate | 9 | | | |
| | | | | Moderate to severe | 14 | | | |
| | | | | Severe | 20 | | | |
| Moderate | 0 | | | | | | | |
| | High | 4 | | | | | | |
| Some difficulty | 0 | Unlimited | 0 | Over 5 blocks | 0 | |||
| | Great difficulty | 10 | | 31-60 min. | 2 | | 1-5 blocks | 4 |
| | Unable to do most ADL | 20 | | 11-30 min. | 4 | | Less than 1 block | 8 |
| | | | | 2-10 min. | 6 | | Household ambulatory | 13 |
| | | | | 2 < min. or indoors only | 8 | | | |
| | | | | Unable to walk | 10 | | | |
| | | | None | 0 | None | 0 | ||
| | | | | Mild | 2 | | Mild | 2 |
| | | | | Moderate | 4 | | Moderate | 4 |
| | | | | Severe | 10 | | Severe (unable to do most activities) | 10 |
| No/does not work | 0 | Not threatened or difficult | 0 | Not threatened but more difficult | 0 | |||
| | Yes | 10 | | | | | | |
| | | | | Not threatened but more difficult | 4 | | Threatened but not immediately | 7 |
| Yes | 0 | | | | | | | |
| | No | 9 | | Threatened, but not immediately | 6 | | Immediately threatened | 10 |
| No | 0 | | | | | | | |
| Yes | 6 | Immediately threatened | 10 | |||||
*Catalan Agency for Health Technology Assessment [62]; **Clinical Priority Assessment Criteria [63].***Western Canada Waiting List Program [65] (asks about situation over the past three months).